ESCO ASTER PTE LTD
Xiangliang (XL) Lin is the Founder, President, and CEO of ESCO ASTER PTE LTD, leading the company as a cGMP/GMP CRDMO that operates on a patented Tide Motion Adherent Cell Platform. Lin also holds the position of Founder and President at Esco Healthcare, where strategic leadership is provided for new product development and oversight of engineering, manufacturing, and validation of downflow booths and Aseptic Isolators. As the Founder, President, and CEO of Esco VacciXcell and Esco TaPestle Rx, Lin focuses on addressing global healthcare challenges through innovative vaccine manufacturing solutions and automation-centered design for medical workflows. In addition, Lin serves as Group Deputy CEO of Esco Micro Pte Ltd, responsible for market development and strategic sales initiatives across the company's life science tools. Lin received a Bachelor of Science degree from the University of Sydney.
This person is not in any teams
This person is not in any offices
ESCO ASTER PTE LTD
Esco Aster is a vertically-integrated contract research (CRO), contract development and manufacturing organization (CDMO) founded and deeply rooted by scientists enabling fellow scientists to translate their benchwork into life-saving diagnostics, medicines, therapies, cosmeceuticals, and cellular agriculture, at affordable prices for self-sufficiency of the country. We make complex manufacturing simple via our proprietary best-in-class continuous manufacturing platforms providing a reliable and linearly scalable outcome with a track record of being used in 7 commercial human and animal health vaccines. We continuously invest in meeting unmet clinical needs by unlocking manufacturing bottlenecks for current and new platform modalities. Together, we are working on an interconnected one health approach to bring your next molecule into the clinic and life. Join us for the world we are making redefining food and medicine for the current and future generations to come. Esco Aster. One World. One Health.